ConductScience.org, home

Paper30967904

Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation.

Filgueira NA. World J Hepatol, 2019. Cited by 111 papers, by iCite.

Cite this record

ConductScience Library. Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation. Papers, record 30967904. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30967904

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation.
PubMed
Journal
World J Hepatol
PubMed
Year
2019
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
111
iCite
Relative citation ratio, by iCite
5.36
iCite
Revised in PubMed
2020-09-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Filgueira NANorma Arteiro

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111391528Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.Hepatology2001https://conductscience.org/library/papers/11391528PubMed
215048797Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.Liver Transpl2004https://conductscience.org/library/papers/15048797PubMed
316386569Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma?Transplant Proc2005https://conductscience.org/library/papers/16386569PubMed
417539001Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.Liver Transpl2007https://conductscience.org/library/papers/17539001PubMed
518497692Use of the piggyback hepatectomy technique in liver transplant recipients with hepatocellular carcinoma.Transplantation2008https://conductscience.org/library/papers/18497692PubMed
618650514Sorafenib in advanced hepatocellular carcinoma.N Engl J Med2008https://conductscience.org/library/papers/18650514PubMed
719058754Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.Lancet Oncol2009https://conductscience.org/library/papers/19058754PubMed
819561458Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma.Ann Surg2009https://conductscience.org/library/papers/19561458PubMed
920070666Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor.Am J Transplant2010https://conductscience.org/library/papers/20070666PubMed
1021143097Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.Exp Clin Transplant2010https://conductscience.org/library/papers/21143097PubMed
1121334400The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.J Hepatol2011https://conductscience.org/library/papers/21334400PubMed
1221502763High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.Digestion2011https://conductscience.org/library/papers/21502763PubMed
1321584928Which matters most: number of tumors, size of the largest tumor, or total tumor volume?Liver Transpl2011https://conductscience.org/library/papers/21584928PubMed
1421695773Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.Liver Transpl2011https://conductscience.org/library/papers/21695773PubMed
1521850692Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.Liver Transpl2012https://conductscience.org/library/papers/21850692PubMed
1621953139Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.Dig Dis Sci2012https://conductscience.org/library/papers/21953139PubMed
1722047762Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.Lancet Oncol2012https://conductscience.org/library/papers/22047762PubMed
1822151471Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation.Transpl Int2012https://conductscience.org/library/papers/22151471PubMed
1922339891Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study.World J Surg Oncol2012https://conductscience.org/library/papers/22339891PubMed
2022710887Factors predicting survival after post-transplant hepatocellular carcinoma recurrence.J Hepatobiliary Pancreat Sci2013https://conductscience.org/library/papers/22710887PubMed

See all 77 referencesDownload CSV of references

Cited by81

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.

PMIDTitleJournalYearIn PapersSource
42930145Machine Perfusion and Oncologic Outcomes After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Curr Oncol2026https://conductscience.org/library/papers/42930145PubMed
42477564The role of machine perfusion in preventing recurrence after liver transplant for hepatocellular carcinoma: a systematic review and meta-analysis.BMC Gastroenterol2026https://conductscience.org/library/papers/42477564PubMed
42131696Screening and care of patients with graft cirrhosis following liver transplantation.Can Liver J2026https://conductscience.org/library/papers/42131696PubMed
42130302Outcomes of early-stage hepatocellular carcinoma patients treated by resection or ablation: real-life data from the French Administrative Health Care database.J Liver Cancer2026https://conductscience.org/library/papers/42130302PubMed
42122246Recurrence of Colorectal Cancer After Liver Transplant for Isolated Colorectal Liver Metastases: A Narrative Review.Cancers (Basel)2026https://conductscience.org/library/papers/42122246PubMed
42073543Anti-Tumor Immunity in Solid-Organ Transplant Recipients.Cancers (Basel)2026https://conductscience.org/library/papers/42073543PubMed
41899182Pre-Transplant Natural Killer Cell Activity Predicts Survival and Tumor Recurrence After Living Donor Liver Transplantation.J Clin Med2026https://conductscience.org/library/papers/41899182PubMed
41892169Systemic Treatment for Hepatocellular Carcinoma Recurrence After Liver Transplantation.Curr Oncol2026https://conductscience.org/library/papers/41892169PubMed
41647833Stereotactic radiation therapy for post-transplant systemic recurrence of hepatocellular carcinoma: safety, efficacy and a nomogram predicting overall survival.Front Oncol2025https://conductscience.org/library/papers/41647833PubMed
41063733China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).Liver Cancer2025https://conductscience.org/library/papers/41063733PubMed
41035640HDAC inhibitor MS275 reprograms metabolism to induce differentiation and suppress proliferation in hepatocellular carcinoma.Front Immunol2025https://conductscience.org/library/papers/41035640PubMed
40810857Clinical progression and predictors of renal outcomes following liver transplantation: long-term follow-up results from a Taiwanese center.Updates Surg2026https://conductscience.org/library/papers/40810857PubMed
40808313Review Article: Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors.Aliment Pharmacol Ther2025https://conductscience.org/library/papers/40808313PubMed
40702163Prognostic nomogram for recurrence of hepatocellular carcinoma after liver transplantation for decision making on postoperative adjuvant therapy.Sci Rep2025https://conductscience.org/library/papers/40702163PubMed
40589998Advancing Adjuvant Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review.Immunotargets Ther2025https://conductscience.org/library/papers/40589998PubMed
40557335Cytomegalovirus Reactivation Is Associated With Lower Rates of Hepatocellular Carcinoma Recurrence After Liver Transplantation.Transpl Int2025https://conductscience.org/library/papers/40557335PubMed
40492030A β-glucosidase extracted from walnut (Juglans regia L.) green husk induces human hepatoma cell apoptosis via ROS-mediated p53 and NF-κB pathway.Food Sci Biotechnol2025https://conductscience.org/library/papers/40492030PubMed
40458255Long-Term Survival and Recurrence in HCC vs. Non-HCC Liver Transplant Recipients: A Two-Decade Longitudinal Analysis.J Clin Exp Hepatol2025https://conductscience.org/library/papers/40458255PubMed
40413459
Accuracy of cross-sectional imaging in predicting tumor viability using the LI-RADS treatment response algorithm after image-guided percutaneous ablation with radiologic-pathologic explant correlation.
Cancer Imaging2025https://conductscience.org/library/papers/40413459PubMed
40104187Hepatocellular carcinoma recurrence after liver transplant: An Australian single-centre study.World J Transplant2025https://conductscience.org/library/papers/40104187PubMed

See all 81 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADIPOQ9370PubTator's text mininghttps://conductscience.org/library/genes/9370NCBI Gene
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
LEP3952PubTator's text mininghttps://conductscience.org/library/genes/3952NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30967904

GET https://conductscience.org/api/papers/v1/30967904/references?page=2